Role of calcium in gentamicin-induced mesangial cell activation

被引:13
|
作者
Martínez-Salgado, C [1 ]
Rodríguez-Barbero, A [1 ]
Tavares, P [1 ]
Eleno, N [1 ]
López-Novoa, JM [1 ]
机构
[1] Univ Salamanca, Dept Fisiol & Farmacol, Edificio Dept, Salamanca 37007, Spain
关键词
calcium; gentamicin; mesangial cells; contraction; proliferation; calcium antagonists; platelet activating factor (PAF);
D O I
10.1159/000016335
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Gentamicin-induced decreases in glomerular filtration rate have been associated to a marked decline in the glomerular capillary ultrafiltration coefficient which could be due to an active contraction of mesangial cells. In the present work we assessed a possible role of cytosolic Ca2+ as a mediator that leads to contraction and proliferation induced by gentamicin on mesangial cells. Gentamicin (10(-5)M) induced an increase in cytosolic free Ca2+, that was fully inhibited by the calcium channel blocker, verapamil, and by the endoplasmic reticulum calcium release blocker, TMB-8. Gentamicin induced a planar surface area reduction in cultured mesangial cells, that was blunted by verapamil and TMB-8. Gentamicin also stimulated [H-3]thymidine incorporation into DNA and increased viable cell number, effects that were reduced by both, verapamil and TMB-8. Gentamicin stimulated the expression of the AP1 protein; this expression was partially blunted by verapamil and TMB-8. Moreover, verapamil inhibited gentamicin-induced PAF synthesis from mesangial cells. in summary, gentamicin directly raised intracellular Ca2+ activating both calcium influx from external medium and calcium release from internal stores. This increase is responsible of cellular activation (contraction and proliferation) and PAF synthesis induced by gentamicin on mesangial cells. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:65 / 72
页数:8
相关论文
共 50 条
  • [21] Somatostatin and Gentamicin-Induced Auditory Hair Cell Loss
    Caelers, Antje
    Monge, Arianne
    Brand, Yves
    Bodmer, Daniel
    LARYNGOSCOPE, 2009, 119 (05): : 933 - 937
  • [22] CHARACTERISTICS OF GENTAMICIN-INDUCED NEPHROPATHY
    KAHN, T
    WIENER, P
    BOSCH, J
    KIDNEY INTERNATIONAL, 1976, 10 (06) : 559 - 559
  • [23] GENTAMICIN-INDUCED FANCONI SYNDROME
    RUSSO, JC
    ADELMAN, RD
    JOURNAL OF PEDIATRICS, 1980, 96 (01): : 151 - 153
  • [24] Beneficial Effects of Calcium Oral Coadministration in Gentamicin-Induced Nephrotoxicity in Rats
    Stojiljkovic, Nenad
    Stoiljkovic, Milan
    Mihailovic, Dragan
    Randjelovic, Pavle
    Ilic, Sonja
    Gocmanac-Ignjatovic, Marija
    Veljkovic, Milica
    RENAL FAILURE, 2012, 34 (05) : 622 - 627
  • [25] GENTAMICIN-INDUCED FANCONI SYNDROME
    VANDAELE, MC
    CORBEEL, L
    VANDECASSEYE, W
    STANDAERT, L
    JOURNAL OF PEDIATRICS, 1980, 97 (03): : 507 - 507
  • [26] THE ROLE OF GRAVITY IN GENTAMICIN-INDUCED TOXIC EFFECTS IN A RABBIT MODEL
    LIM, JI
    ANDERSON, CT
    HUTCHINSON, A
    BUGGAGE, RR
    GROSSNIKLAUS, HE
    ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (10) : 1363 - 1367
  • [27] Sulforaphane Attenuates Gentamicin-Induced Nephrotoxicity: Role of Mitochondrial Protection
    Negrette-Guzman, Mario
    Huerta-Yepez, Sara
    Noel Medina-Campos, Omar
    Lucia Zatarain-Barron, Zyanya
    Hernandez-Pando, Rogelio
    Torres, Ismael
    Tapia, Edilia
    Pedraza-Chaverri, Jose
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2013, 2013
  • [28] GENTAMICIN-INDUCED HYPERCALCIURIA IN THE RAT
    CHAHWALA, SB
    HARPUR, ES
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1983, 53 (05): : 358 - 362
  • [29] Role of thyroid hormone in protecting against gentamicin-induced nephrotoxicity
    Gomes, GN
    Silva, VLC
    Cavanal, MD
    Gil, FZ
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (04): : 278 - 287
  • [30] Gentamicin-induced nephrotoxicosis in lambs
    Fadel, AA
    Larkin, HA
    RESEARCH IN VETERINARY SCIENCE, 1996, 61 (03) : 187 - 192